Moiramide B

CAS No. 155233-31-1

Moiramide B( —— )

Catalog No. M36494 CAS No. 155233-31-1

Moiramide B is a potent acetyl coenzyme A carboxylase (ACC) inhibitor (IC50:6 nM) with antimicrobial activity, strongly inhibiting Gram-positive bacteria but weakly inhibiting Gram-negative bacteria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1492 In Stock
25MG 2442 In Stock
50MG 2957 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Moiramide B
  • Note
    Research use only, not for human use.
  • Brief Description
    Moiramide B is a potent acetyl coenzyme A carboxylase (ACC) inhibitor (IC50:6 nM) with antimicrobial activity, strongly inhibiting Gram-positive bacteria but weakly inhibiting Gram-negative bacteria.
  • Description
    Moiramide B is a potent acetyl-CoA carboxylase (ACC) inhibitor with an IC50 value of 6 nM. Moiramide B has antibacterial activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Acetyl-CoA Carboxylase | Antibiotic
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    155233-31-1
  • Formula Weight
    453.53
  • Molecular Formula
    C25H31N3O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C([C@@H](NC(C[C@H](NC(/C=C/C=C/C)=O)C1=CC=CC=C1)=O)[C@@H](C)C)(=O)[C@H]2[C@H](C)C(=O)NC2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cifone MT, et, al. Heterobivalent Inhibitors of Acetyl-CoA Carboxylase: Drug Target Residence Time and Time-Dependent Antibacterial Activity. J Med Chem. 2022 Dec 22;65(24):16510-16525.??
molnova catalog
related products
  • Promethazine Sulfoxi...

    Promethazine sulfoxide is a metabolite of the histamine H1 receptor antagonist Promethazine.It is formed from promethazine by the cytochrome P450 (CYP) isoform CYP2D6.

  • Lomibuvir

    Lomibuvir (VCH-222) is a selective, non-nucleoside allosteric inhibitor of HCV NS5B polymerase (RdRp) with a Kd of 17 nM. Lomibuvir inhibits the 1b/Con1 HCV subgenomic replicon with an EC 50 of 5.2 nM.

  • Esculentoside A

    Esculentoside A can suppress inflammatory responses in LPS-induced ALI through inhibition of the NF-κB and mitogen-activated protein kinase signaling pathways.